In This Section

AACR VIRTUAL PATIENT ADVOCATE FORUM: THE TRANSFORMATIVE POTENTIAL OF BIOMARKERS

Tuesday, August 23, 2022; 1 – 3:30 p.m. ET/ 10 a.m.- 12:30 p.m. PT

Register Today

Each person’s cancer has a unique pattern of biomarkers, making biomarker testing a critical part of diagnostics and treatment. This Forum will explore where and how biomarkers are changing cancer research and care to benefit patients with cancer.

MODERATOR

Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine of USC, Los Angeles, California

SPEAKERS

Steven D. Averbuch, MD,  S.D. Averbuch Consulting, LLC, Princeton, New Jersey

George D. Demetri, MD, FAACR, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Jill Feldman, AACR Scientist↔Survivor Program®, EGFR Resisters, Chicago, Illinois

Joshua LaBaer, MD, PhD, Arizona State University, Biodesign Institute, Tempe, Arizona

Laura van ‘t Veer, PhD, UCSF Hellen Diller Family Comprehensive Cancer Center, San Francisco, California

Program Agenda Speaker Bios

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and health care communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public. 


Special thanks to our supporters

Bristol Myers Squibb
Daiichi-Sankyo
Pfizer Oncology